JEFFREY W SHERMAN
CIK 1230482 · EVP and Chief Medical Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.14M
Companies
5
Total Filings
83
Lifetime Open-Market Net
-$31.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LRMR | Director | 5,000 | $4.16 | $20.8K | $25.0K | 5 | 2026-05-20 |
| XERS | Director | 266,820 | $7.93 | $2.12M | -$324.4K | 11 | 2025-08-29 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP and Chief Medical Officer | 0 | $116.30 | $0 | -$30.85M | 55 | 2023-10-06 |
| Strongbridge Biopharma plc (SBBP) Delisted | Director | 0 | $2.00 | $0 | $0 | 8 | 2021-10-06 |
| IDM PHARMA, INC. (IDMI) Delisted | Sr. VP, R & D and CMO | — | — | — | $0 | 2 | 2008-04-07 |
Recent Filings · Page 3 of 9
83 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-09 | XERS | Grant (A) | +15,000 | $0 | EDGAR |
| 2022-04-08 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Sell (S) | −42,009 | -$4.62M | EDGAR |
| 2022-03-21 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +8,531 | $188.9K | EDGAR |
| 2022-01-24 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +2,982 | -$205.0K | EDGAR |
| 2022-01-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +47,146 | $0 | EDGAR |
| 2021-10-29 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Exer (M) | +10,729 | $81.6K | EDGAR |
| 2021-10-06 | Strongbridge Biopharma plc (SBBP) Delisted | Disp (D) | −64,258 | $0 | EDGAR |
| 2021-10-05 | Strongbridge Biopharma plc (SBBP) Delisted | Tax (F) | −17,763 | -$36.6K | EDGAR |
| 2021-10-05 | — | Grant (A) | +50,378 | $0 | |
| 2021-10-05 | XERS | Disp (D) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.